23andMe, the Mountain View-based genetic testing and analysis company, is raising close to $200 million in a funding round led by Sequoia Capital, multiple sources tell us. Sources say that Fidelity is also looking to participate. We’d first heard in spring that the 11-year-old company was looking for more money to expand its genetics research arm and develop new products. The fresh… Read More